🇺🇸 FDA
Patent

US 8324258

F1F0-ATPase inhibitors and related methods

granted A61PA61P17/00A61P17/02

Quick answer

US patent 8324258 (F1F0-ATPase inhibitors and related methods) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P17/00, A61P17/02, A61P17/06, A61P19/00